The Diabetes Biologics market was valued at USD 20.30 Billion in 2024 and is expected to reach USD 48.94 Billion by 2032, growing at a CAGR of 11.6% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research R